Related Experiment Video

Updated: Aug 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Nosocomial pneumonia experienced in a community hospital]

Y Kobashi1, J Tanabe, K Fujita

  • 1Department of Medicine, Kawasaki Medical School Kawasaki Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|January 23, 1999
PubMed

Insights

Nosocomial pneumonia in community hospitals is linked to older age, prolonged stays, and respiratory conditions. Treatment challenges arise from multi-drug resistant pathogens, leading to high mortality rates.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Nosocomial pneumonia presents unique challenges in community hospital settings.
  • Understanding its specific characteristics is crucial for effective patient management.

Purpose of the Study:

  • To elucidate the defining features of nosocomial pneumonia within a community hospital environment.
  • To identify risk factors, common pathogens, and treatment outcomes.

Main Methods:

  • A clinical analysis was conducted on 147 patients (155 episodes) diagnosed with nosocomial pneumonia.
  • Data collected included patient demographics, clinical status, causative microorganisms, and treatment strategies.

Main Results:

  • Key risk factors identified: age over 65, prolonged admission (>1 month), poor performance status, and underlying respiratory diseases.
  • Methicillin-resistant Staphylococcus aureus (MRSA) was a frequent causative agent, often multi-drug resistant.
  • Treatment involved prolonged antibiotic courses, mechanical ventilation (31%), and steroid pulse therapy (24%), with a high mortality rate of 50%.

Conclusions:

  • Nosocomial pneumonia in this setting is associated with significant risk factors and frequently involves multi-drug resistant organisms.
  • Treatment difficulties are attributed to patient comorbidities and the emergence of resistant, polymicrobial infections.
  • The observed high mortality underscores the severity and complexity of managing nosocomial pneumonia in community hospitals.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...